Age-related Macular Degeneration
Showing NaN - NaN of 15
Age-Related Macular Degeneration Trial in Iowa City, Baltimore, Portland (RetinoStat)
Active, not recruiting
- Age-Related Macular Degeneration
-
Iowa City, Iowa
- +2 more
Oct 20, 2021
Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)
Choroidal Neovascularization, Age-related Macular Degeneration Trial in United States (hI-con1, ranibizumab, Sham injection)
Completed
- Choroidal Neovascularization
- Age-related Macular Degeneration
- hI-con1
- +2 more
-
Phoenix, Arizona
- +47 more
Sep 23, 2020
Age-related Macular Degeneration Trial in Baltimore (VMS diary booklet, Standard of Care)
Terminated
- Age-related Macular Degeneration
- VMS diary booklet
- Standard of Care
-
Baltimore, MarylandJohns Hopkins University Wilmer Eye Institute
Aug 12, 2019
Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)
Age-related Macular Degeneration, Subfoveal Choroidal Neovascularization, Subretinal Scarring Trial in Baltimore (RXI-109)
Unknown status
- Age-related Macular Degeneration
- +3 more
-
Baltimore, MarylandWilmer Eye Institute at Johns Hopkins
Feb 22, 2018
Combretastatin A4 Phosphate, Age-related Macular Degeneration, AMD Trial in Baltimore (Combretastatin A-4 phosphate,
Completed
- Combretastatin A4 Phosphate
- +4 more
- Combretastatin A-4 phosphate
- Combretastatin A-4 Phosphate
-
Baltimore, MarylandWilmer Eye Institute
Dec 4, 2017
Precision of the Microperimetry Function of the Spectral OCT/SLO
Completed
- Age-Related Macular Degeneration
- +8 more
-
Fort Lauderdale, Florida
- +2 more
Apr 3, 2017
Age-related Macular Degeneration Trial in United States (Squalamine lactate ophthalmic solution, 0.2%, Placebo Ophthalmic
Unknown status
- Age-related Macular Degeneration
- Squalamine lactate ophthalmic solution, 0.2%
- +2 more
-
Mobile, Alabama
- +117 more
Apr 25, 2017
Age-related Macular Degeneration Trial in United States (Ranibizumab 0.5mg)
Unknown status
- Age-related Macular Degeneration
- Ranibizumab 0.5mg
-
Mountain View, California
- +3 more
Aug 1, 2016
Age-related Macular Degeneration Trial in United States (Ranibizumab)
Completed
- Age-related Macular Degeneration
-
Phoenix, Arizona
- +98 more
Dec 11, 2012
Age-Related Macular Degeneration Trial in Israel, United States (PF-04523655)
Completed
- Age-Related Macular Degeneration
-
Beverly Hills, California
- +10 more
Oct 5, 2012
Age-Related Macular Degeneration Trial in United States (Avastin, Photodynamic Therapy (PDT), Preservative-Free Triamcinolone
Terminated
- Age-Related Macular Degeneration
- Avastin
- +2 more
-
Ft. Lauderdale, Florida
- +10 more
Mar 23, 2010
Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Baltimore, Cleveland (AGN211745)
Completed
- Age-Related Macular Degeneration
- Choroidal Neovascularization
-
Baltimore, Maryland
- +1 more
Aug 14, 2008
Choroidal Neovascularization, Age-Related Macular Degeneration Trial in Baltimore, Portland (Periocular injection of
Completed
- Choroidal Neovascularization
- Age-Related Macular Degeneration
- Periocular injection of triamcinolone acetonide 40mg
-
Baltimore, Maryland
- +1 more
Mar 20, 2006